1 active not recruiting, 1 completed, 1 unknown. 2 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Antithrombotic: new trials by email Literature Review of Antithrombotic trials Research Report on Antithrombotic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In Vivo Evaluation of Anti-inflammatory and Antithrombotic Health Promoting Properties of Extra Virgin Olive Oil Versus Classic Table Olive Oil in Healthy Subjects Olive Oil 1, Olive oil (placebo) 1, Olive Oil 2 - Antiplatelet, Antithrombotic | Not applicable | Active not recruiting | Democritus University of Thrace | 54 | 2025-11-01 | 2026-08-25 |
| Effectiveness of the Application(APP) on Individualized Antithrombotic Therapy intelligent terminal APP - Antithrombotic | Not applicable | Unknown | Guangdong Provincial People's Hospital | 10000 | 2017-11-01 | 2018-05-24 |
| A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis Enoxaparin, unfractionated heparin (UFH), BMS-986177 - Antithrombotic | Phase 1 / Phase 2 | Completed | Bristol-Myers Squibb | 32 | 2017-05-23 | 2020-12-29 |
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Heart Diseases (1) · Myocardial Ischemia (1) · Vascular Diseases (1)
Crossing Over, Genetic (1) · Diet Therapy (1) · Economics (1) · Enoxaparin (1) · Heparin (1) · Olive Oil (1) · milvexian (1)
Bristol-Myers Squibb (1) · Democritus University of Thrace (1) · Guangdong Provincial People's Hospital (1)
China (1) · Greece (1) · United States (1)
Alexandros Tsoupras (1) · Jiyan Chen, M.D. (1)